The Effect of Prolonged Treatment with Belimumab on B cells in Human SLE

OBJECTIVES: To understand the effects of prolonged BLyS inhibition in human SLE. METHODS: 17 SLE patients enrolled in a clinical trial of belimumab, a BLyS-specific inhibitor, plus standard of care therapy were studied. Phenotypic analysis of lymphocytes was performed using flow cytometry. Circulati...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Jacobi, Annett M, Huang, Weiqing, Wang, Tao, Freimuth, William, Sanz, Inaki, Furie, Richard, Mackay, Meggan, Aranow, Cynthia, Diamond, Betty, Davidson, Anne
Format: Artigo
Idioma:Inglês
Publicat: 2010
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2857977/
https://ncbi.nlm.nih.gov/pubmed/20039404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.27189
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars